Paromomycin Sulfate/Gentamicin

硫酸巴龙霉素/庆大霉素

Report date: 2023/04/21 09:51:24

Base Information

Drug NameParomomycin Sulfate/Gentamicin
Drug Alias NameGentamicin Sulfate/Paromomycin Sulfate硫酸庆大霉素/硫酸巴龙霉素巴龙霉素/庆大霉素Paromomycin/gentamicinGentamicin/paromomycin +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsLeishmaniasis, CutaneousLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTunisiaFrance
CombinationsYes Paromomycin SulfateGentamicin Sulfate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesWalter Reed Army Institute
China Registration ClassN/A

Develop Information

Active CompaniesWalter Reed Army Institute
Inactive CompaniesWalter Reed Army Institute Of Research
Active IndicationsLeishmaniasis
Inactive IndicationsLeishmaniasis, Cutaneous

Other Information

ATC CodeN/A
Related LinksN/A